Brighton Jones LLC Eli Lilly & CO Transaction History

Brighton Jones LLC

  • $2.55 Billion
  • Q3 2024

A detailed history of Brighton Jones LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Brighton Jones LLC holds 7,867 shares of LLY stock, worth $6.09 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares
7,867
Previous 11,497 31.57%
Holding current value
$6.09 Million
Previous $10.4 Million 33.05%
% of portfolio
0.27%
Previous 0.35%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024
SELL
$772.14 - $960.02 $2.8 Million - $3.48 Million
-3,630 Reduced 31.57%
7,867 $6.97 Million
Q2 2024

Aug 12, 2024
BUY
$724.87 - $909.04 $35,518 - $44,542
49 Added 0.43%
11,497 $10.4 Million
Q1 2024

May 09, 2024
BUY
$592.2 - $792.28 $1.05 Million - $1.41 Million
1,774 Added 18.34%
11,448 $8.91 Million
Q4 2023

Feb 05, 2024
BUY
$525.19 - $619.13 $303,034 - $357,238
577 Added 6.34%
9,674 $5.64 Million
Q3 2023

Oct 25, 2023
BUY
$434.7 - $599.3 $250,387 - $345,196
576 Added 6.76%
9,097 $4.89 Million
Q2 2023

Jul 31, 2023
SELL
$350.74 - $468.98 $19,290 - $25,793
-55 Reduced 0.64%
8,521 $4 Million
Q1 2023

May 08, 2023
BUY
$310.63 - $364.82 $723,767 - $850,030
2,330 Added 37.3%
8,576 $2.95 Million
Q4 2022

Feb 02, 2023
SELL
$321.55 - $374.67 $59,808 - $69,688
-186 Reduced 2.89%
6,246 $2.29 Million
Q3 2022

Nov 09, 2022
BUY
$296.48 - $337.87 $29,648 - $33,787
100 Added 1.58%
6,432 $2.08 Million
Q2 2022

Aug 04, 2022
BUY
$278.73 - $327.27 $17,559 - $20,618
63 Added 1.0%
6,332 $2.05 Million
Q1 2022

May 13, 2022
BUY
$234.69 - $291.66 $20,887 - $25,957
89 Added 1.44%
6,269 $1.8 Million
Q4 2021

Feb 03, 2022
BUY
$224.85 - $279.04 $39,573 - $49,111
176 Added 2.93%
6,180 $1.71 Million
Q3 2021

Nov 04, 2021
BUY
$221.6 - $272.71 $69,139 - $85,085
312 Added 5.48%
6,004 $1.39 Million
Q2 2021

Aug 10, 2021
SELL
$180.55 - $233.54 $89,913 - $116,302
-498 Reduced 8.05%
5,692 $1.31 Million
Q1 2021

May 07, 2021
BUY
$164.32 - $212.72 $37,300 - $48,287
227 Added 3.81%
6,190 $1.16 Million
Q4 2020

Feb 10, 2021
BUY
$130.46 - $172.63 $39,529 - $52,306
303 Added 5.35%
5,963 $1.01 Million
Q3 2020

Nov 12, 2020
BUY
$146.22 - $169.13 $2,778 - $3,213
19 Added 0.34%
5,660 $838,000
Q2 2020

Aug 11, 2020
SELL
$136.42 - $164.18 $2,864 - $3,447
-21 Reduced 0.37%
5,641 $926,000
Q1 2020

May 13, 2020
SELL
$119.05 - $147.35 $154,765 - $191,555
-1,300 Reduced 18.67%
5,662 $785,000
Q4 2019

Feb 07, 2020
BUY
$106.92 - $132.43 $12,402 - $15,361
116 Added 1.69%
6,962 $915,000
Q3 2019

Oct 28, 2019
BUY
$106.79 - $116.16 $21,571 - $23,464
202 Added 3.04%
6,846 $766,000
Q2 2019

Aug 05, 2019
SELL
$110.79 - $129.32 $3,212 - $3,750
-29 Reduced 0.43%
6,644 $736,000
Q1 2019

Apr 26, 2019
BUY
$111.31 - $131.02 $149,489 - $175,959
1,343 Added 25.2%
6,673 $866,000
Q4 2018

Feb 08, 2019
BUY
$105.9 - $118.64 $14,720 - $16,490
139 Added 2.68%
5,330 $617,000
Q3 2018

Nov 07, 2018
SELL
$85.86 - $107.31 $1,717 - $2,146
-20 Reduced 0.38%
5,191 $557,000
Q2 2018

Aug 06, 2018
SELL
$75.7 - $86.88 $74,943 - $86,011
-990 Reduced 15.97%
5,211 $445,000
Q1 2018

May 03, 2018
SELL
$74.21 - $87.6 $75,768 - $89,439
-1,021 Reduced 14.14%
6,201 $480,000
Q4 2017

Feb 08, 2018
BUY
$81.94 - $87.89 $9,996 - $10,722
122 Added 1.72%
7,222 $610,000
Q3 2017

Nov 08, 2017
SELL
$77.07 - $85.54 $40,692 - $45,165
-528 Reduced 6.92%
7,100 $607,000
Q2 2017

Aug 08, 2017
BUY
N/A
7,628
7,628 $628,000

Others Institutions Holding LLY

# of Institutions
4,012
Shares Held
751M
Call Options Held
8.27M
Put Options Held
10.5M
View Full List

About ELI LILLY & Co

LLY Quotes by TradingView
  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $735B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Brighton Jones LLC Portfolio

Follow Brighton Jones LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brighton Jones LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brighton Jones LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email